ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
3,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
5,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
7,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
8,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
9,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
9,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
10,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
11,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
12,1,Arrhythmia supraventricular,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
12,2,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
13,1,Albuminuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
14,1,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
15,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
16,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
17,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
18,1,Blood fibrinogen decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
19,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
20,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
21,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
21,2,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
21,3,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
21,4,Vasoconstriction,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
22,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
23,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
24,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
24,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,Y
24,3,Right ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
24,4,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
25,1,Akinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
25,2,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
25,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
25,4,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
25,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
26,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
26,2,Optic ischaemic neuropathy,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
26,3,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
27,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
28,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
29,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
30,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
32,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
32,2,Extremity necrosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
33,1,Extremity necrosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
